Document is current
Any future updates will be listed below
-
Authors
Nadeu, Ferran https://orcid.org/0000-0003-2910-9440
Shuai, Shimin https://orcid.org/0000-0002-9527-8018
Clot, Guillem https://orcid.org/0000-0003-2588-7413
Hilton, Laura K. https://orcid.org/0000-0002-6413-6586
Diaz-Navarro, Ander
Martín, Silvia
Royo, Romina
Baumann, Tycho
Kulis, Marta
López-Oreja, Irene
Cossio, Manuel
Lu, Junyan https://orcid.org/0000-0002-9211-0746
Ljungström, Viktor
Young, Emma
Plevova, Karla https://orcid.org/0000-0002-6148-8877
Knisbacher, Binyamin A.
Lin, Ziao
Hahn, Cynthia K.
Bousquets, Pablo https://orcid.org/0000-0002-2969-008X
Alcoceba, Miguel https://orcid.org/0000-0002-3819-4846
González, Marcos
Colado, Enrique https://orcid.org/0000-0001-8675-8207
Payer, Ángel R.
Aymerich, Marta
Terol, María J.
Rivas-Delgado, Alfredo
Enjuanes, Anna
Ruiz-Gaspà, Sílvia
Chatzikonstantinou, Thomas https://orcid.org/0000-0003-4105-1253
Hägerstrand, Daniel https://orcid.org/0000-0001-7270-0776
Jylhä, Cecilia
Skaftason, Aron
Mansouri, Larry
Stranska, Kamila https://orcid.org/0000-0001-7678-1163
Doubek, Michael https://orcid.org/0000-0002-1269-6282
van Gastel-Mol, Ellen J.
Davis, Zadie
Walewska, Renata
Scarfò, Lydia https://orcid.org/0000-0002-0844-0989
Trentin, Livio https://orcid.org/0000-0003-1222-6149
Visentin, Andrea https://orcid.org/0000-0003-0271-7200
Parikh, Sameer A. https://orcid.org/0000-0002-3221-7314
Rabe, Kari G. https://orcid.org/0000-0002-7313-1875
Moia, Riccardo https://orcid.org/0000-0001-7393-1138
Armand, Marine https://orcid.org/0000-0001-8906-3128
Rossi, Davide
Davi, Frederic
Gaidano, Gianluca https://orcid.org/0000-0002-4681-0151
Kay, Neil E. https://orcid.org/0000-0002-5951-5055
Shanafelt, Tait D.
Ghia, Paolo https://orcid.org/0000-0003-3750-7342
Oscier, David
Langerak, Anton W. https://orcid.org/0000-0002-2078-3220
Beà, Sílvia https://orcid.org/0000-0001-7192-2385
López-Guillermo, Armando
Neuberg, Donna https://orcid.org/0000-0003-2566-3145
Wu, Catherine J. https://orcid.org/0000-0002-3348-5054
Getz, Gad https://orcid.org/0000-0002-0936-0753
Pospisilova, Sarka https://orcid.org/0000-0001-7136-2680
Stamatopoulos, Kostas https://orcid.org/0000-0001-8529-640X
Rosenquist, Richard https://orcid.org/0000-0002-0211-8788
Huber, Wolfgang
Zenz, Thorsten https://orcid.org/0000-0001-7890-9845
Colomer, Dolors https://orcid.org/0000-0001-7486-8484
Martín-Subero, José I. https://orcid.org/0000-0001-8809-5195
Delgado, Julio https://orcid.org/0000-0002-5157-4376
Morin, Ryan D. https://orcid.org/0000-0003-2932-7800
Stein, Lincoln D.
Puente, Xose S. https://orcid.org/0000-0001-9525-1483
Campo, Elías https://orcid.org/0000-0001-9850-9793
-
Funding
Funding for this research was provided by:
European Hematology Association (RG-202012-00245)
- License Information
-
More Information
Article History
Received: 3 January 2025
Revised: 19 May 2025
Accepted: 13 June 2025
First Online: 30 June 2025
Competing interests
: FN received honoraria from AbbVie, AstraZeneca, Janssen, and SOPHiA GENETICS for speaking at educational activities, and research funding from Gilead. LS received honoraria from AbbVie, AstraZeneca, BeiGene, Johnson&Johnson, Lilly, and Merck. AWL received research support and/or speaker fee from Johnson & Johnson and Roche-Genentech. PG received honoraria from AbbVie, ArQule/MSD, AstraZeneca, BeiGene, Celgene/Juno/BMS, Janssen, Lilly/LoxoSanofi and Roche, and research support from AbbVie, AstraZeneca, and Janssen. RRos received honoraria from AbbVie, AstraZeneca, Illumina, Janssen, and Roche. DN has stock ownership in Madrigal Pharmaceuticals. GGa has received honoraria from Abbvie, AstraZeneca, Beigene, Hikma, Incyte, Johnson & Johnson, Lilly for speaking at educational activities and advisory boards. CJW holds equity in BioNTech, Inc. and receives research support from Pharmacyclics. GGe receives research funds from IBM and Pharmacyclics; is an inventor on patent applications related to MuTect, ABSOLUTE, MutSig, MSMuTect, MSMutSig, MSIDetect, POLYSOLVER and TensorQTL; and is a founder and consultant of and holds privately held equity in Scorpion Therapeutics. LDS received support from the Province of Ontario and the Canadian Institutes for Health Research, grant #202003PJT-438161-CBT-OICR-168885. XSP is a cofounder of and holds an equity stake in DREAMgenics, and received honoraria from AstraZeneca and BeiGene for speaking at educational activities. EC has been a consultant for Takeda; received honoraria from Janssen, ThermoFisher and Roche for speaking at educational activities; and is an inventor on a Lymphoma and Leukemia Molecular Profiling Project patent “Method for subtyping lymphoma subtypes by means of expression profiling” (PCT/US2014/64161) not related to this project. FN and EC licensed the use of the protected IgCaller algorithm for SOPHiA GENETICS and Diagnóstica Longwood. The other authors have no competing interests to declare.
